Univariate associations of clinical factors with odds for FL response to ixazomib monotherapy
| Variable . | OR (95% CI) . | P value . |
|---|---|---|
| Bulky disease (GELF) | 1.1 (0.2-7.3) | .89 |
| Extranodal disease | 0.2 (0.03-1.6) | .14 |
| FLIPI∗ | 3.9 (1.1-14.1) | .04 |
| Largest tumor ≥7 cm | 0.9 (0.1-6.8) | .92 |
| LDH∗ | 1.0 (1.0-1.0) | .20 |
| Variable . | OR (95% CI) . | P value . |
|---|---|---|
| Bulky disease (GELF) | 1.1 (0.2-7.3) | .89 |
| Extranodal disease | 0.2 (0.03-1.6) | .14 |
| FLIPI∗ | 3.9 (1.1-14.1) | .04 |
| Largest tumor ≥7 cm | 0.9 (0.1-6.8) | .92 |
| LDH∗ | 1.0 (1.0-1.0) | .20 |
LDH, lactate dehydrogenase.
Modeled as continuous linear variables; OR represents increase in odds associated with each 1-unit increase in variable.